Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

eISSN: 2581-9615 || CODEN: WJARAI || Impact Factor 8.2 ||  CrossRef DOI

Research and review articles are invited for publication in March 2026 (Volume 29, Issue 3) Submit manuscript

Oculopharyngeal muscular dystrophy, rare genetic disorder: A case report

Breadcrumb

  • Home
  • Oculopharyngeal muscular dystrophy, rare genetic disorder: A case report

George Trad 1, 5, 6, *, Nazanin Sheikhan 2, 5, 6, Victoria, Diaz 3, 5, 6, Eujean Park 2, 5, 6 and Gemil Hatim 4, 5, 6

1 PGY2, Department of Internal Medicine Sunrise Health GME Consortium 2880 N Tenaya Way 2nd Floor Las Vegas, NV, USA. ***
2 PGY2, Department of Internal Medicine Sunrise Health GME Consortium Las Vegas, NV, USA. 
3 PGY1, Department of Internal Medicine Sunrise Health GME Consortium Las Vegas, NV, USA. 
4 Faculty Attending, Department of Internal Medicine Sunrise Health GME Consortium Las Vegas, NV, USA.
5 Mountain View Medical Center, Las Vegas, NV, USA.
6 HCA Healthcare, Nashville, TN, USA.
 
Case Study
World Journal of Advanced Research and Reviews, 2022, 14(01), 140-143
Article DOI: 10.30574/wjarr.2022.14.1.0300
DOI url: https://doi.org/10.30574/wjarr.2022.14.1.0300
 
Received on 02 March 2022; revised on 05 April 2022; accepted on 07 April 2022
 
Oculopharyngeal muscular dystrophy (OPMD) is a rare genetic disease that targets the muscles of the eyelids and pharynx. OPMD is caused by an abnormal expansion of a trinucleotide repeat (GCG) in the coding region of poly-A binding protein nuclear 1 gene (PABPN-1). Patients with OPMD present mainly with ptosis, dysphagia, and extremity weakness. Herein, we present a case report of a patient with OPMD. Our case report will provide detailed information regarding the outpatient management of OPMD, as well as possible therapies of the future for these patients.
 
Oculopharyngeal Muscular Dystrophy; Ptosis; Dysphagia; Outpatient Therapy
 
https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2022-0300.pdf

Preview Article PDF

George Trad, Nazanin Sheikhan, Victoria, Diaz, Eujean Park and Gemil Hatim. Oculopharyngeal muscular dystrophy, rare genetic disorder: A case report. World Journal of Advanced Research and Reviews, 2022, 14(1), 140-143. Article DOI: https://doi.org/10.30574/wjarr.2022.14.1.0300

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 World Journal of Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution